[ 68 Ga]‑DOTA‑conjugated somatostatin receptor‑targeting peptide PET for the differentiation between...
[ 68 Ga]‑DOTA‑conjugated somatostatin receptor‑targeting peptide PET for the differentiation between meningioma and glioblastoma: A case report and review of the literature
About this item
Full title
Author / Creator
Publisher
Athens: Spandidos Publications UK Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Athens: Spandidos Publications UK Ltd
Subjects
More information
Scope and Contents
Contents
[68Ga]-tetraazacyclododecanetetraacetic acid (DOTA)-conjugated positron emission tomography (PET) is widely used to identify meningiomas due to their high expression of somatostatin receptor type 2 (SSTR2). However, recent evidence suggests that this tracer may also show uptake in high-grade gliomas, raising concerns about its diagnostic specificit...
Alternative Titles
Full title
[ 68 Ga]‑DOTA‑conjugated somatostatin receptor‑targeting peptide PET for the differentiation between meningioma and glioblastoma: A case report and review of the literature
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11883336
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11883336
Other Identifiers
ISSN
1792-1074
E-ISSN
1792-1082
DOI
10.3892/ol.2025.14945
